Global 3D Drug Eluting Balloons Applications in Healthcare Market, by Component (Devices, Materials, and Services), By Technology (Droplet Deposition, Photo Polymerization, Laser Beam Melting, Electronic Beam Melting, and Laminated Object Manufacturing), Application (External Wearable Devices, Clinical Study Devices, Implants, and Tissue Engineering), and End-User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, and Academic Institutions), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

3D Drug Eluting Balloons Applications in Healthcare Market Overview:

The global 3D drug-eluting balloons applications in the healthcare market are projected to reach a valuation of USD 569.81 Mn by 2031 at a CAGR of 1.40%, from USD 495.85 Mn in 2021.

Market.US announces the publication of a recently generated research report titled (Market.Us has compiled a research report titled), “Global 3D Drug Eluting Balloons Applications in Healthcare Market, by Component (Devices, Materials, and Services), By Technology (Droplet Deposition, Photo Polymerization, Laser Beam Melting, Electronic Beam Melting, and Laminated Object Manufacturing), Application (External Wearable Devices, Clinical Study Devices, Implants, and Tissue Engineering), and End-User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, and Academic Institutions), and by Region – Global Forecast to 2031.” This report offers a holistic view of the Global 3D Drug Eluting Balloons Applications in the Healthcare Market through systematic segmentation that covers every aspect of this target market.

3D drug-eluting balloons are designed to release a therapeutic agent in controlled time intervals. They are capable of providing sustained drug delivery for chronic diseases, such as pulmonary hypertension. 3D drug-eluting balloons are often made from silicone or polyurethane film, which are shaped into a balloon-like shape and implanted at a site where the blood vessels narrow.

3D drug-eluting balloons are made out of biocompatible materials, so they can remain in the body for an extended period of time. This is beneficial because it reduces the need for repeat surgeries to remove them. This also decreases the risks of complications such as infections or toxic reactions to the balloons during surgery.

3D drug-eluting balloons are a new technology that is being used to treat different types of cancer. These balloons can be injected into cancerous tumors and will dissolve over time, delivering chemotherapy drugs directly to a tumor site while limiting the amount of harmful radiation that gets released.

Drug Eluting Balloons (DEBs) are used to treat coronary artery disease and peripheral arterial disease. DEBs consist of a drug and a polymer, and these components can be combined in a variety of ways to produce different balloon sizes and shapes. These drug-based balloons were approved by the United States Food and Drug Administration in 1990, but they have only been extensively used since the early 2000s for coronary artery disease treatment.

The 3D drug-eluting balloons applications in healthcare is a relatively new way of treating health disorders. Unlike traditional methods, which are invasive and sometimes painful, this new technology is not only convenient but also painless. Furthermore, it’s less time-consuming than other treatments. With the 3D Drug Eluting Balloon (DEB), doctors can help patients avoid an invasive surgery that generally comes with higher risks such as potential infection or additional tissue damage.

Global 3D Drug Eluting Balloons Applications in Healthcare Market Revenue (US$ Mn), 2021–2031

The healthcare industry is undergoing significant change due to the emergence of treatment techniques such as the use of 3D drug-eluting balloons. These advancements are pushing the boundaries of modern medicine and providing new solutions for challenging health conditions.

With the increase in global populations, there is an increasing need for global healthcare solutions to address chronic conditions, such as heart disease, diabetes, cancer, and chronic lung diseases. Healthcare leaders are looking for new ways to improve patient survival rates and their quality of life thereafter. 3D DEBs are a new way to deliver drugs directly to a specific target area within the body – bypassing the diseased region.

The use of 3D drug-eluting balloons reduces costly hospital stays while providing patients with a safer alternative to traditional treatment options. As healthcare providers seek new ways to reduce costs without sacrificing quality, 3D drug-eluting balloons are being used in nearly all aspects of medicine, from emergency medicine to patient recovery.

The high cost of this treatment prevents it from becoming widely available to the general medical community. Further research is needed to develop less expensive, alternative materials in order to make this treatment more affordable for patients around the world.

Drug-eluting balloons have been used in the medical field for many years, however, the 3D variety has only recently become popular. The use of these modern balloons, especially in cardiology, is rapidly growing. As this technology improves and becomes more widely accepted, its application will continue to increase among patients looking for cardiac disorder relief.

The demand for 3D drug-eluting balloons applications in healthcare market opportunities is thriving due to the number of new 3D drug-eluting balloons that are making their way for use in this market. One example is the EGP-3003D, a 3D drug-eluting balloon that has been recently launched by GE Healthcare.

The global 3D drug-eluting balloons applications in the healthcare market have grown significantly since it was first introduced. These balloons can be used to treat a range of diseases and symptoms, such as variceal bleeding from portal hypertension, acute pancreatitis, and also large pulmonary emboli. In addition to this, the balloon is generally accepted by patients, as it is significantly less invasive than surgery or endoscopic treatment.

The application of 3D drug-eluting balloons is still in its infancy, but it is nonetheless growing in popularity. A team at China Medical University used 3D printing to print an implantable drug elution balloon capable of delivering medication to specific areas within the body, which are determined by CT scans. The balloon is fitted with a special additive that turns into rigid porous scaffolding which can hold the balloon in place for weeks or even months.

In recent years, the application of 3D drug-eluting balloons has been found to have a variety of benefits. The use of these balloons has increased over the years for many reasons including a decrease in post-balloon procedures, a high rate of efficacy, and a lower risk for complications. Although this type of procedure is not new, it has been gaining popularity due to its effectiveness and convenience as an alternative to endoscopy.

In February 2018, AMBER (Advanced Materials and Bioengineering Research) partnered with Johnson & Johnson to develop a 3D bio print center of excellence.

Market Key Players:

The research report on the global 3D drug-eluting balloons applications in the healthcare market includes major company profiles such as

• ExOne
• 3D Systems Inc.
• HP Development Company L.P.
• Proto Labs Ltd.
• Stratasys Ltd.
• SLM Solutions
• and Nano Dimension
• among others.

The Global 3D Drug Eluting Balloons Applications in Healthcare Market Segmentation is Based on Component, Technology, Application, End-User, and Region

Based on Component

• Devices
• Materials
• Services

Based on Technology

• Droplet Deposition
• Photo Polymerization
• Laser Beam Melting
• Electronic Beam Melting
• Laminated Object Manufacturing

Based on Application

• External Wearable Devices
• Clinical Study Devices
• Implants
• Tissue Engineering

Based on End-User

• Medical & Surgical Centers
• Pharmaceutical & Biotechnology Companies
• Academic Institutions

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa